Diagnostic Yield of Cardiac CT to Detect Cardiac Thrombi in Acute Ischemic Stroke: an Individual Patient Data Meta-Analysis

NCT ID: NCT07165093

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3940 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-19

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the AIS of HEARTS registry is to establish a database to collect, maintain and provide accessible individual patient data from international cohorts and to provide pooled analyses about the yield and value of cardiac computed tomography (CT), acquired during the initial stroke imaging protocol.

The main analysis will investigate the diagnostic yield of cardiac CT to detect cardioembolic sources of stroke in acute ischemic stroke patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is an individual patient data meta-analysis of four different cohorts (4 hospitals) with both prospective and retrospective data. Patients are included if they underwent cardiac CT (ECG gated or non-ECG gated) acquired during the acute stroke scan protocol. The main paper will focus on the diagnostic yield of cardiac thrombi detected on cardiac CT acquired during the acute stroke scan protocol, the comparison with echocardiography and the 90 day follow-up outcomes.

Prospectively planned subanalyses from the AIS of HEARTS registry:

Beyond the analyses focussed on cardiac thrombi, the investigators have prespecified the following analyses:

* Risk stratification of cardioembolic sources in acute ischemic stroke to improve decision making in performing a cardiac CT
* Short term clinical implications of cardiac thrombi detected on cardiac CT
* Long term clinical implications of cardiac thrombi detected on cardiac CT
* Diagnostic yield of ECG-gated versus non-ECG-gated cardiac CT in the acute phase of ischemic stroke
* Association between left atrial appendage contrast filling characteristics and recurrent stroke
* Association between left atrial appendage (LAA) morphology/volume and LAA thrombus
* Cardiac thrombus and associations with medium vessel occlusions strokes
* High-risk cardioembolic sources on cardiac CT in TIA patients
* Clinical relevance of valvular vegetations detected on cardiac CT
* Long term clinical implications of left atrial diverticula detected on cardiac CT
* Incidental findings on cardiac CT The investigators are planning to perform these additional analyses once the main paper has been accepted/submitted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke Cardioembolic Stroke Thrombus Cardiac CT

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Amsterdam UMC

Patients from Amsterdam UMC that underwent ECG-gated cardiac CT

No interventions assigned to this group

Christchurch Hospital

Patients from Christchurch hospital that underwent non-ECG gated cardiac CT

No interventions assigned to this group

John Hunter Hospital

Patients from John Hunter Hospital that underwent non-ECG gated cardiac CT

No interventions assigned to this group

Liverpool Hospital

Patients from Liverpool Hospital that underwent ECG-gated cardiac CT

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or older
* Clinical diagnosis of acute ischemic stroke
* Cardiac CT acquired during acute stroke scan protocol

Exclusion Criteria

* Transient ischemic attack
* Stroke mimics
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jonathan Coutinho

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonathan Coutinho, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Amsterdam UMC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amsterdam UMC

Amsterdam, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL64139.018.18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The SMARTER Cardiomyopathy Study
NCT05750147 RECRUITING
The ALERT-Pilot Study
NCT03317691 UNKNOWN
Biomarkers in Acute Cardiac Care
NCT02355457 RECRUITING